Penumbra
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.About PEN
Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system.
CEOAdam Elsesser
CEOAdam Elsesser
Employees4,500
Employees4,500
HeadquartersAlameda, California
HeadquartersAlameda, California
Founded2004
Founded2004
Employees4,500
Employees4,500
PEN Key Statistics
Market cap12.55B
Market cap12.55B
Price-Earnings ratio74.42
Price-Earnings ratio74.42
Dividend yield—
Dividend yield—
Average volume495.80K
Average volume495.80K
High today$315.01
High today$315.01
Low today$311.41
Low today$311.41
Open price$312.77
Open price$312.77
Volume407.05K
Volume407.05K
52 Week high$315.01
52 Week high$315.01
52 Week low$221.26
52 Week low$221.26
Stock Snapshot
Penumbra(PEN) stock is priced at $312.02, giving the company a market capitalization of 12.55B. It carries a P/E multiple of 74.42.
On 2025-12-12, Penumbra(PEN) stock traded between a low of $311.41 and a high of $315.01. Shares are currently priced at $312.02, which is +0.2% above the low and -0.9% below the high.
The Penumbra(PEN)'s current trading volume is 407.05K, compared to an average daily volume of 495.8K.
During the past year, Penumbra(PEN) stock moved between $221.26 at its lowest and $315.01 at its peak.
During the past year, Penumbra(PEN) stock moved between $221.26 at its lowest and $315.01 at its peak.
Analyst ratings
81%
of 21 ratingsBuy
81%
Hold
14.3%
Sell
4.8%
People also own
Based on the portfolios of people who own PEN. This list is generated using Robinhood data, and it’s not a recommendation.